|
|
Anti-Proliferative and water
Estrogen and androgen signaling in the pathogenesis of BPH.
Nature reviews. Urology
Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane.
Endocrinology
Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation.
Endocrinology
Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolism.
Nutrition and cancer
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Breast cancer research and treatment
The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.
Endocrine-related cancer
Estrogen receptor beta binds to and regulates three distinct classes of target genes.
The Journal of biological chemistry
An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo.
Endocrinology
Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia.
Reproductive biology and endocrinology : RB&E
The role of estrogen receptor beta (ERbeta) in malignant diseases--a new potential target for antiproliferative drugs in prevention and treatment of cancer.
Biochemical and biophysical research communications
Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.
Molecular cancer therapeutics
2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Bioorganic & medicinal chemistry
Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer.
Cancer biology & therapy
Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Proceedings of the National Academy of Sciences of the United States of America
Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature.
Breast cancer (Tokyo, Japan)
Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells.
Journal of molecular endocrinology
Synthesis, biological evaluation, structural-activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators.
Bioorganic & medicinal chemistry
Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.
Oncology reports
Nature reviews. Urology
Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane.
Endocrinology
Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation.
Endocrinology
Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolism.
Nutrition and cancer
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Breast cancer research and treatment
The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.
Endocrine-related cancer
Estrogen receptor beta binds to and regulates three distinct classes of target genes.
The Journal of biological chemistry
An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo.
Endocrinology
Identification of ERbeta1 and ERbeta2 in human seminoma, in embryonal carcinoma and in their adjacent intratubular germ cell neoplasia.
Reproductive biology and endocrinology : RB&E
The role of estrogen receptor beta (ERbeta) in malignant diseases--a new potential target for antiproliferative drugs in prevention and treatment of cancer.
Biochemical and biophysical research communications
Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.
Molecular cancer therapeutics
2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Bioorganic & medicinal chemistry
Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer.
Cancer biology & therapy
Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.
Proceedings of the National Academy of Sciences of the United States of America
Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature.
Breast cancer (Tokyo, Japan)
Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptin-resistant breast cancer cells.
Journal of molecular endocrinology
Synthesis, biological evaluation, structural-activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators.
Bioorganic & medicinal chemistry
Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.
Oncology reports
Get breaking news about nutritional cures, dangerous chemicals, superfoods and more.
Subscribe to the FREE Natural News email newsletter. Your privacy is protected.
See more studies on Anti-Proliferative and...
How is this determined?
The order of these related concepts is determined by a statistical analysis of the scientific literature. Highest-frequency concepts appear first.
|
Proliferative 7844 Antiproliferative 6469 cancer 3519 Tumor 2343 Apoptotic 1017 Cytotoxic 927 Toxicity 848 breast cancer 762 Cytotoxicity 602 Leukemia 516 prostate 420 Death 398 Melanoma 350 Inflammatory 349 Cell cycle arrest 333 Vitamin 332 prostate cancer 304 colon cancer 295 Tyrosine 288 lead 275 blood 262 Chemotherapeutic 253 Antiviral 206 lymphoma 186 Chemopreventive 180 skin 176 |
Vitamin D 164 chemotherapy 149 ethanol 146 Enzymes 131 water 125 Flavonoids 116 ovarian cancer 115 Calcium 111 Iron 76 Sulfate 67 Quercetin 62 Gastric cancer 54 oxidative stress 54 Curcumin 52 Resveratrol 51 Polyphenols 49 diphenyl 44 Phytochemicals 40 liver cancer 39 Vegetables 31 ginseng 28 Interstitial cystitis 23 Apigenin 23 thyroid 22 Raspberry 22 |
